August 15, 2024 – Imidazolidin

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for

Chemexpress August 15, 2024 0 Comments

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for the trial to detect ROS1-rearrangement can be a locally created laboratory-based test and no formal CDx is being developed…

Uncategorized

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K

Chemexpress August 15, 2024 0 Comments

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K, anti-P-S6K, anti-S6, anti-P-S6, anti-4EBP1, anti-P-4EBP1, or anti-HA antibodies. Anti-GAPDH was employed to verify equal protein loading. The…

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K

You Missed

2-Methoxy-N-methylaniline (CAS 10541-78-3)

2-methoxy-3-methylbenzohydrazide (CAS 288154-71-2)

2-mercapto-7-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-4(3H)-thione

2-mercapto-3-(tetrahydrofuran-2-ylmethyl)-3,5-dihydro-4H-imidazol-4-one